TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES
6.1. Overview
6.2. Workflow
6.3. Product
6.4. Services
7. GLOBAL MESENCHYMAL STEM CELLS MARKET, BY TYPE
7.1. Overview
7.2. Autologous
7.3. Allogenic
8. GLOBAL MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION
8.1. Overview
8.2. Bone marrow
8.3. Cord blood
8.4. Peripheral blood
8.5. Fallopian Tube
8.6. Fetal Liver
8.7. Lung and Adipose Tissues
9. GLOBAL MESENCHYMAL STEM CELLS MARKET, BY INDICATION
9.1. Overview
9.2. Bone and cartilage repair
9.3. Cardiovascular disease
9.4. Inflammatory & immunological diseases
9.5. Liver diseases
9.6. Cancer
9.7. GvHD
9.8. Others
10. GLOBAL MESENCHYMAL STEM CELLS MARKET, BY APPLICATION
10.1. Overview
10.2. Disease modeling
10.3. Drug development & discovery
10.4. Stem cell banking
10.5. Tissue engineering
10.6. Toxicology studies
10.7. Others
11. GLOBAL MESENCHYMAL STEM CELLS MARKET, BY REGION
11.1. Overview
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global Mesenchymal Stem Cells Market,
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Global Mesenchymal Stem Cells Market,
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2023
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. Lonza Group
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. Thermo Fisher Scientific Inc.
13.2.1. Company Overview
13.2.2. Financial Overview
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. Merck KGaA
13.3.1. Company Overview
13.3.2. Financial Overview
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. StemCells Inc.
13.4.1. Company Overview
13.4.2. Financial Overview
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. Mesoblast Ltd.
13.5.1. Company Overview
13.5.2. Financial Overview
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Cellular Dynamics International
13.6.1. Company Overview
13.6.2. Financial Overview
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. PromoCell GmbH
13.7.1. Company Overview
13.7.2. Financial Overview
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. CELGENE CORPORATION
13.8.1. Company Overview
13.8.2. Financial Overview
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. Osiris Therapeutics, Inc.
13.9.1. Company Overview
13.9.2. Financial Overview
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. PLURISTEM THERAPEUTICS INC.
13.10.1. Company Overview
13.10.2. Financial Overview
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL MESENCHYMAL STEM CELLS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL MESENCHYMAL STEM CELLS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 12 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 13 US: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 14 US: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 15 US: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 16 US: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 17 US: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 CANADA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 19 CANADA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 CANADA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 21 CANADA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 22 CANADA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 23 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 24 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 25 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 26 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 27 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 28 GERMANY: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 29 GERMANY: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 30 GERMANY: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 31 GERMANY: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 32 GERMANY: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 FRANCE: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 34 FRANCE: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 35 FRANCE: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 36 FRANCE: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 37 FRANCE: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 38 ITALY: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 39 ITALY: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 40 ITALY: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 41 ITALY: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 42 ITALY: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 43 SPAIN: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 44 SPAIN: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 45 SPAIN: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 46 SPAIN: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 47 SPAIN: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 UK: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 49 UK: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 UK: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 51 UK: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 52 UK: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 53 REST OF EUROPE: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 54 REST OF EUROPE: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 55 REST OF EUROPE: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 56 REST OF EUROPE: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 57 REST OF EUROPE: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 58 ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 59 ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 60 ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 61 ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 62 ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 63 JAPAN: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 64 JAPAN: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 65 JAPAN: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 66 JAPAN: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 67 JAPAN: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 68 CHINA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 69 CHINA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 70 CHINA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 71 CHINA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 72 CHINA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 73 INDIA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 74 INDIA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 75 INDIA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 76 INDIA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 77 INDIA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 78 AUSTRALIA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 79 AUSTRALIA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 80 AUSTRALIA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 81 AUSTRALIA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 82 AUSTRALIA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 83 SOUTH KOREA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 84 SOUTH KOREA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 85 SOUTH KOREA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 86 SOUTH KOREA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 87 SOUTH KOREA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 88 REST OF ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 89 REST OF ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 90 REST OF ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 91 REST OF ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 92 REST OF ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 93 REST OF THE WORLD: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 94 REST OF THE WORLD: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 95 REST OF THE WORLD: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 96 REST OF THE WORLD: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 97 REST OF THE WORLD: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 98 MIDDLE EAST: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 99 MIDDLE EAST: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 100 MIDDLE EAST: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 101 MIDDLE EAST: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 102 MIDDLE EAST: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 103 AFRICA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 104 AFRICA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 105 AFRICA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 106 AFRICA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 107 AFRICA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 108 LATIN AMERICA: MESENCHYMAL STEM CELLS MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)
TABLE 109 LATIN AMERICA: MESENCHYMAL STEM CELLS MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 110 LATIN AMERICA: MESENCHYMAL STEM CELLS MARKET, BY SOURCE OF ISOLATION, 2019-2032 (USD BILLION)
TABLE 111 LATIN AMERICA: MESENCHYMAL STEM CELLS MARKET, BY INDICATION, 2019-2032 (USD BILLION)
TABLE 112 LATIN AMERICA: MESENCHYMAL STEM CELLS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MESENCHYMAL STEM CELLS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MESENCHYMAL STEM CELLS MARKET
FIGURE 4 GLOBAL MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY PRODUCTS & SERVICES, 2023
FIGURE 5 GLOBAL MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY TYPE, 2023
FIGURE 6 GLOBAL MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY SOURCE OF ISOLATION, 2023
FIGURE 7 GLOBAL MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY INDICATION, 2023
FIGURE 8 GLOBAL MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 9 GLOBAL MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 EUROPE: MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 ASIA-PACIFIC: MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 REST OF THE WORLD: MESENCHYMAL STEM CELLS MARKET, SHARE (%), BY REGION, 2023
FIGURE 14 GLOBAL MESENCHYMAL STEM CELLS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 15 LONZA GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 LONZA GROUP: SWOT ANALYSIS
FIGURE 17 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 19 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 MERCK KGAA: SWOT ANALYSIS
FIGURE 21 STEMCELLS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 STEMCELLS INC.: SWOT ANALYSIS
FIGURE 23 MESOBLAST LTD..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 MESOBLAST LTD..: SWOT ANALYSIS
FIGURE 25 CELLULAR DYNAMICS INTERNATIONAL: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 CELLULAR DYNAMICS INTERNATIONAL: SWOT ANALYSIS
FIGURE 27 PROMOCELL GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 PROMOCELL GMBH: SWOT ANALYSIS
FIGURE 29 CELGENE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 CELGENE CORPORATION: SWOT ANALYSIS
FIGURE 31 OSIRIS THERAPEUTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 OSIRIS THERAPEUTICS, INC.: SWOT ANALYSIS
FIGURE 33 PLURISTEM THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 PLURISTEM THERAPEUTICS INC.: SWOT ANALYSIS
